Our latest news, announcements and multimedia resources
Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA® (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival (DMFS) in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus KEYTRUDA
Read our latest news releases.
Read our latest company statements.
Access videos, logos, photos and infographics.
Global media relations
We are driven by a single purpose
We use the power of leading-edge science to save and improve lives around the world.
Find our latest financials, events & presentations, news, stock information and investor contacts.
Company fact sheet
Access company information including stock ticker, official company names, description, and more.